EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Changes in 1‐year relative survival of patients with cancer during the COVID ‐19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population‐based cohort study

Fernando Gonzalez Yli-Mäyry iD, Tomas Tanskanen, Karri Seppä, Anna L V Johansson iD, Charlotte Wessel Skovlund, Lina Steinrud Mørch, Søren Friis, Simon Mathis Kønig, Tom Børge Johannesen, Tor Åge Myklebust, Sasha Pejicic, David Pettersson und 7 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70336 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Fernando Gonzalez Yli-Mäyry und 18 weiteren Autor:innen. Beteiligte Einrichtung: Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nordic Cancer Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the first year of the COVID‐19 pandemic, reported cancer cases declined in the Nordic countries, potentially reflecting delays in cancer diagnosis. We compared 1‐year relative survival (RS) and excess mortality of patients diagnosed with cancer in the Nordic countries in March–December 2020 with that expected based on patients diagnosed in 2011–2019. We used flexible parametric RS models, defining excess mortality as the difference in total mortality between patients with cancer and the national population without cancer. We report the ratio between the observed and expected excess mortality (EMR) and the difference in 1‐year RS in percentage points (pp) by country, age, sex, and cancer site. Excess mortality of patients diagnosed during the pandemic was increased in all Nordic countries except Iceland. Swedish men had the highest EMR of 1.12 (95% CI 1.06, 1.17), corresponding to a 1.4 pp reduction in 1‐year RS (87.1%–85.8%). In women, the highest EMR was 1.10 (95% CI 1.03, 1.18) in Norway, corresponding to a 1‐year RS decrease of 1.2 pp (86.6%–85.5%). The largest site‐specific decreases in 1‐year RS were observed for liver cancer in Finnish and Swedish men, with decreases of 10.2 pp (45.3%–35.1%) and 7.2 pp (55.7%–48.5%), respectively. We found reduced 1‐year RS among Nordic patients diagnosed with cancer during the COVID‐19 pandemic in 2020, especially in older patients and those with aggressive cancers. These reductions coincided with restrictions and potential delays in seeking healthcare.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedCohort StudiesDenmarkFinlandIcelandNorwayPandemicsSARS-CoV-2Scandinavian and Nordic CountriesScandinavians and Nordic PeopleSurvival RateSweden

Stichwörter der Autor:innen

COVID‐19Nordic countriesSARS‐CoV‐2excess mortalityrelative survival

Autor:innen und Institutionen

  • Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland.
  • Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
  • Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.
  • National Board of Health and Welfare, Stockholm, Sweden.

ORCID-Profile: Fernando Gonzalez Yli-Mäyry, Anna L V Johansson, Joonas Miettinen

Förderung

  • Nordic Cancer Union

Zitieren

APA

Yli-Mäyry, F. G., Tanskanen, T., Seppä, K., Johansson, A. L. V., Skovlund, C. W., Mørch, L. S., Friis, S., Kønig, S. M., Johannesen, T. B., Myklebust, T. Å., Pejicic, S., Pettersson, D., Guðmundsdóttir, E. M., Heinävaara, S., Malila, N., Miettinen, J., Ahlgren, J., Ursin, G., & Pitkäniemi, J. (2026). Changes in 1‐year relative survival of patients with cancer during the COVID ‐19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population‐based cohort study. International Journal of Cancer. https://doi.org/10.1002/ijc.70336

Vancouver

Yli-Mäyry FG, Tanskanen T, Seppä K, Johansson ALV, Skovlund CW, Mørch LS, et al. Changes in 1‐year relative survival of patients with cancer during the COVID ‐19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population‐based cohort study. International Journal of Cancer. 2026. doi:10.1002/ijc.70336

BibTeX
@article{YliMyry2026,
  author = {Yli-Mäyry, Fernando Gonzalez and Tanskanen, Tomas and Seppä, Karri and Johansson, Anna L V and Skovlund, Charlotte Wessel and Mørch, Lina Steinrud and Friis, Søren and Kønig, Simon Mathis and Johannesen, Tom Børge and Myklebust, Tor Åge and Pejicic, Sasha and Pettersson, David and Guðmundsdóttir, Eva María and Heinävaara, Sirpa and Malila, Nea and Miettinen, Joonas and Ahlgren, Johan and Ursin, Giske and Pitkäniemi, Janne},
  title = {Changes in 1‐year relative survival of patients with cancer during the COVID ‐19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population‐based cohort study},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70336}
}
Kostenlos starten →